Research Ethics and Policy Series (REPS): Holly Fernandez Lynch, JD, MBe "Trial Selection and Prioritization at Research Sites: Learning from Oncology and COVID-19"

Trial Selection and Prioritization at Research Sites: Learning from Oncology and COVID-19

Holly Fernandez Lynch, JD, MBe

Assistant Professor of Medical Ethics
Assistant Faculty Director, MEHP Online Educational Initiatives
Assistant Professor of Law
Perelman School of Medicine, University of Pennsylvania
 

Clinical trials require access to limited site-level resources: patients, staff, and infrastructure. Without careful selection between acceptable studies, the most important may be delayed, fail to adequately enroll, or never launch. Prioritization is therefore ethically critical but to date has not received much bioethical attention beyond consideration of how sponsors allocate funding.

This lecture will describe a conceptual ethical framework for site-level trial prioritization and provide insights from a pair of interview studies examining how research institutions decided which COVID-19 studies to pursue during the height of the pandemic and how NCI-funded cancer centers select which oncology protocols will be allowed to proceed.

Lunch provided.
Streaming available via Zoom.